On-line symposium pre-test:

Multiple Sclerosis - From Who Gets It to How Much Does it Cost to Treat

Please complete this pre-test so that we can evaluate the knowledge gained by participating in this CME activity.

Please answer the questions below by marking the appropriate choice..
      
 
A
B
C
D
E
1. Multiple Sclerosis is a disease of all but:

a. Myelin

b. Gray Matter

c. Axons

d. Schwann cells


   
A
B
C
D
E

2. Multiple Sclerosis is a disease involving:

a. Kidneys

b. Bladder

c. Small intestine

d. Immune system


   
A
B
C
D
E

3. Multiple sclerosis pathology involves all but:

a. Inflammation

b. Degeneration

c. Immune activity

d. Amyloid plaques


   
A
B
C
D
E

4. The epidemiology of MS closely mimics the distribution of:

a. Vitamin A

b. Vitamin B

c. Vitamin C

d. Vitamin D


   
A
B
C
D
E

5. The modern classification of MS includes all but:

a. Relapsing-Remitting MS

b. Chronic Progressive

c. Secondary progressive MS

d. Progressive Relapsing MS


   
A
B
C
D
E

6. The FDA approved treatments of an MS relapse include all but

a. Intravenous methylprednisolone

b. Intramuscular ACTH

c. Cyclophosphamide


   
A
B
C
D
E
7. What factor is not involved in selecting an immune modulating treatment:

    a. Managed care

    b. Personality of the individual

    c. The pattern of the MS

    d. The pharmaceutical company’s marketing


   
A
B
C
D
E
8. The most likely first oral immune modulating agent to be approved by the FDA will be:

    a. Fingolimod

    b. Cladribine

    c. Dalfampridine

    d. Methylprednisolone


             
After completing the questions above, please provide your email address. A corrected post-test will be emailed to the address below.
           
Email Address